Blueshift Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Blueshift Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $214,640 - $227,000	2,000 New	2,000 $218,000
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $297,511 - $436,000	3,747 Added 41.94%	12,682 $1.01 Million
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $142,938 - $181,625	1,654 Added 22.72%	8,935 $940,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $40,409 - $49,163	410 Added 5.97%	7,281 $785,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $338,412 - $406,382	3,682 Added 115.46%	6,871 $753,000
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $581,861 - $647,172	-6,747 Reduced 67.9%	3,189 $299,000
Q1 2021 May 06, 2021	BUY	$71.83 - $95.48 $447,572 - $594,935	6,231 Added 168.18%	9,936 $915,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $248,235 - $312,664	3,705 New	3,705 $271,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.